Sodium channel γENaC mediates IL-17 synergized high salt induced inflammatory stress in breast cancer cells

Cellular Immunology

Volumn 302, Issue , 2016, Pages 1-10

  Amara, Suneetha ^a   Ivy, Michael T ^b   Myles, Elbert L ^b   Tiriveedhi, Venkataswarup ^b  

^a MERCY HOSPITAL   (United States)

^b TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cytokine; Epithelial sodium channel (ENaC); Inflammation; Interleukin 17

Indexed keywords

EPITHELIAL SODIUM CHANNEL; INTERLEUKIN 17; INTERLEUKIN 6; NITROGEN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; CARCINOGEN; SODIUM CHLORIDE;

ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; STRESS; TUMOR MICROENVIRONMENT; UPREGULATION; BREAST TUMOR; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL SODIUM CHANNELS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; SODIUM CHLORIDE; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 84960101252     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.12.007     Document Type: Article

References (50)

1. Kim S., Takahashi H., Lin W.W., Descargues P., Grivennikov S., Kim Y., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
2. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
3. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
4. Okada F. Inflammation and free radicals in tumor development and progression. Redox Rep. 2002, 7:357-368.
5. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
6. Landskron G., De la Fuente M., Thuwajit P., Thuwajit C., Hermoso M.A. Chronic inflammation and cytokines in the tumor microenvironment. J. Immunol. Res. 2014, 2014:149185.
7. Braumuller H., Wieder T., Brenner E., Assmann S., Hahn M., Alkhaled M., et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013, 494:361-365.
8. Murugaiyan G., Saha B. Protumor vs antitumor functions of IL-17. J. Immunol. 2009, 183:4169-4175.
9. Ernst M., Putoczki T. IL-17 cuts to the chase in colon cancer. Immunity 2014, 41:880-882.
10. Cochaud S., Giustiniani J., Thomas C., Laprevotte E., Garbar C., Savoye A.M., et al. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Sci. Rep. 2013, 3:3456.
11. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999, 59:3698-3704.
12. Numasaki M., Watanabe M., Suzuki T., Takahashi H., Nakamura A., McAllister F., et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 2005, 175:6177-6189.
13. Zhang F., Tang Z., Hou X., Lennartsson J., Li Y., Koch A.W., et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc. Natl. Acad. Sci. USA 2009, 106:6152-6157.
14. Mozaffari M.S., Patel C., Ballas C., Schaffer S.W. Effects of excess salt and fat intake on myocardial function and infarct size in rat. Life Sci. 2006, 78:1808-1813.
15. Ketonen J., Mervaala E. Effects of dietary sodium on reactive oxygen species formation and endothelial dysfunction in low-density lipoprotein receptor-deficient mice on high-fat diet. Heart Vessels 2008, 23:420-429.
16. Tsugane S., Sasazuki S., Kobayashi M., Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br. J. Cancer 2004, 90:128-134.
17. Sparks R.L., Pool T.B., Smith N.K., Cameron I.L. Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo. Cancer Res. 1983, 43:73-77.
18. Wu C., Yosef N., Thalhamer T., Zhu C., Xiao S., Kishi Y., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
19. Leavy O. T cells: salt promotes pathogenic TH17 cells. Nat. Rev. Immunol. 2013, 13:225.
20. Platt D., Amara S., Mehta T., Vercuyssee K., Myles E.L., Johnson T., et al. Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis. Biochem. Biophys. Res. Commun. 2014, 455:107-112.
21. Amara S., Lopez K., Banan B., Brown S.K., Whalen M., Myles E., et al. Synergistic effect of pro-inflammatory TNFalpha and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol. Immunol. 2015, 64:26-35.
22. Tiriveedhi V., Angaswamy N., Brand D., Weber J., Gelman A.G., Hachem R., et al. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin. Exp. Immunol. 2012, 167:158-168.
23. He D., Li H., Yusuf N., Elmets C.A., Athar M., Katiyar S.K., et al. IL-17 mediated inflammation promotes tumor growth and progression in the skin. PLoS One 2012, 7:e32126.
24. Liou G.Y., Storz P. Reactive oxygen species in cancer. Free Radic. Res. 2010, 44:479-496.
25. Papa L., Hahn M., Marsh E.L., Evans B.S., Germain D. SOD2 to SOD1 switch in breast cancer. J. Biol. Chem. 2014, 289:5412-5416.
26. Blaug S., Hybiske K., Cohn J., Firestone G.L., Machen T.E., Miller S.S. ENaC- and CFTR-dependent ion and fluid transport in mammary epithelia. Am. J. Physiol. Cell Physiol. 2001, 281:C633-C648.
27. BoydNaray-Fejes-Toth C. A., Steroid-mediated regulation of the epithelial sodium channel subunits in mammary epithelial cells. Endocrinology 2007, 148:3958-3967.
28. Schilli R., Breuer R.I., Klein F., Dunn K., Gnaedinger A., Bernstein J., et al. Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis. Gut 1982, 23:326-332.
29. Tiriveedhi V., Angaswamy N., Weber J., Mohanakumar T. Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: role in pathogenesis of chronic rejection following human lung transplantation. Biochem. Biophys. Res. Commun. 2010, 399:251-255.
30. Nicod M., Michlig S., Flahaut M., Salinas M., Fowler Jaeger N., Horisberger J.D., et al. A novel vasopressin-induced transcript promotes MAP kinase activation and ENaC downregulation. EMBO J. 2002, 21:5109-5117.
31. Ley R., Balmanno K., Hadfield K., Weston C., Cook S.J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 2003, 278:18811-18816.
32. Ma Z., Webb D.J., Jo M., Gonias S.L. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J. Cell Sci. 2001, 114:3387-3396.
33. Kostourou V., Cartwright J.E., Johnstone A.P., Boult J.K., Cullis E.R., Whitley G., et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. Br. J. Cancer 2011, 104:83-90.
34. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 1995, 72:41-44.
35. Rios-Arrabal S., Artacho-Cordon F., Leon J., Roman-Marinetto E., Del Mar Salinas-Asensio M., Calvente I., et al. Involvement of free radicals in breast cancer. Springerplus 2013, 2:404.
36. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5:14.
37. Huang P., Feng L., Oldham E.A., Keating M.J., Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000, 407:390-395.
38. Punnonen K., Ahotupa M., Asaishi K., Hyoty M., Kudo R., Punnonen R. Antioxidant enzyme activities and oxidative stress in human breast cancer. J. Cancer Res. Clin. Oncol. 1994, 120:374-377.
39. Papa L., Manfredi G., Germain D. SOD1, an unexpected novel target for cancer therapy. Genes Cancer 2014, 5:15-21.
40. Finley L.W., Carracedo A., Lee J., Souza A., Egia A., Zhang J., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011, 19:416-428.
41. Rossier B.C., Canessa C.M., Schild L., Horisberger J.D. Epithelial sodium channels. Curr. Opin. Nephrol. Hypertens. 1994, 3:487-496.
42. Soundararajan R., Pearce D., Hughey R.P., Kleyman T.R. Role of epithelial sodium channels and their regulators in hypertension. J. Biol. Chem. 2010, 285:30363-30369.
43. Wang X.F., Lu X.M., Lin R.Y., Wang S.Z., Zhang L.P., Qian J., et al. Lack of association of functional variants in alpha-ENaC gene and essential hypertension in two ethnic groups in China. Kidney Blood Press. Res. 2008, 31:268-273.
44. + channel in essential hypertension. Hypertension 1998, 32:129-137.
45. Roger S., Besson P., Le Guennec J.Y. Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim. Biophys. Acta 2003, 1616:107-111.
46. Masilamani S., Kim G.H., Mitchell C., Wade J.B., Knepper M.A. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J. Clin. Invest. 1999, 104:R19-R23.
47. Svensson S., Jirstrom K., Ryden L., Roos G., Emdin S., Ostrowski M.C., et al. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 2005, 24:4370-4379.
48. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
49. Kroke A., Klipstein-Grobusch K., Voss S., Moseneder J., Thielecke F., Noack R., et al. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am. J. Clin. Nutr. 1999, 70:439-447.
50. Tsubono Y., Takahashi T., Iwase Y., Iitoi Y., Akabane M., Tsugane S. Nutrient consumption and gastric cancer mortality in five regions of Japan. Nutr. Cancer 1997, 27:310-315.